Select country set
Menu Shopping cart 0,00 Search
Distributed product

Anti-OVA-IgE Mouse ELISA

  • Regulatory status:RUO
  • Type:Direct ELISA, Biotin-labelled antibody
  • Other names:anti-Ovalbumin
  • Species:Mouse
Please select your region to see available products and prices.
Cat. No. Size Price

633-07659 96 wells (1 kit)
PubMed Product Details
Technical Data

Cat # changed from RSHAKRIE030R to 633-07659


Direct ELISA, Biotin-labelled antibody


Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate

Sample Requirements

5 µl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1.88–120 U/ml

Limit of Detection

0.094 U/ml

Intra-assay (Within-Run)

n = 5; CV = 5%

Inter-assay (Run-to-Run)

n = 3; CV = 5%


Research topic

Animal studies


IgE (immunoglobulin E) is the 5th immunoglobulin found and is composed of 2 heavy chains which contain 5 domains (VH, CH 1-4) and 2 light chains. It is a glycoprotein with molecular weight of 190kDa, and in electrophoresis it moves to 1 region. Metabolic half life of IgE is about 3 days in man, and normal serum level in human is about 300 ng/ml, however, it is markedly increased in parasite infection and hay fever. Allergy-related IgE is called reagin. The Fc region of reagin increased after sensitization with allergens will bind Fc R1 receptor of basophilic granulocytes and mast cells in the skin, respiratory, and digestive organs, and sensitizes those cells.
Those IgE-sensitized cells will be degranulated when the second allergens bind the surface IgE, and release histamine, serotonine, protease, heparin, chemotactic factors, prostaglandins, leucotriens, etc., causing type I allergy reactions. Shibayagi’s OVA-IgE ELISA KIT is a useful tool for studying mouse immune system by measuring specific anti-OVA IgE after immunization of mice with OVA (ovalbumin).

Product References (10)


  • Akiyama K, Karaki M, Kobayshi R, Dobashi H, Ishida T, Mori N. IL-16variability and modulation by antiallergic drugs in a murine experimentalallergic rhinitis model. Int Arch Allergy Immunol. 2009;149(4):315-22. doi:10.1159/000205577. Epub 2009 Mar 17. PubMed PMID: 19295235. See more on PubMed
  • Aloyouni SY, Segeritz CP, Sherrid AM, Gold MJ, Loeffler DI, Blanchet MR, CaiB, Hirota J, McNagny KM, Kollmann TR. Perinatal Immunization With Vaccine-GradeListeria monocytogenes Provides Protection Against Murine Th2 AirwayInflammation. Allergy Asthma Immunol Res. 2014 Jul;6(4):341-9. doi:10.4168/aair.2014.6.4.341. Epub 2014 Mar 21. PubMed PMID: 24991458; PubMedCentral PMCID: PMC4077961. See more on PubMed
  • Fukui N, Honda K, Ito E, Ishikawa K. Peroxisome proliferator-activatedreceptor gamma negatively regulates allergic rhinitis in mice. Allergol Int. 2009Jun;58(2):247-53. doi: 10.2332/allergolint.08-OA-0047. Epub 2009 Mar 25. PubMedPMID: 19307774. See more on PubMed
  • He M, Ichinose T, Yoshida S, Nishikawa M, Mori I, Yanagisawa R, Takano H,Inoue K, Sun G, Shibamoto T. Urban particulate matter in Beijing, China, enhancesallergen-induced murine lung eosinophilia. Inhal Toxicol. 2010 Aug;22(9):709-18. doi: 10.3109/08958371003631608. PubMed PMID: 20560731. See more on PubMed
  • Ichinose T, Yoshida S, Hiyoshi K, Sadakane K, Takano H, Nishikawa M, Mori I,Yanagisawa R, Kawazato H, Yasuda A, Shibamoto T. The effects of microbialmaterials adhered to Asian sand dust on allergic lung inflammation. Arch Environ Contam Toxicol. 2008 Oct;55(3):348-57. doi: 10.1007/s00244-007-9128-8. Epub 2008 Jan 29. PubMed PMID: 18227959. See more on PubMed
  • Ichinose T, Yoshida S, Sadakane K, Takano H, Yanagisawa R, Inoue K, Nishikawa M, Mori I, Kawazato H, Yasuda A, Shibamoto T. Effects of asian sand dust, Arizonasand dust, amorphous silica and aluminum oxide on allergic inflammation in themurine lung. Inhal Toxicol. 2008 May;20(7):685-94. doi: 10.1080/08958370801935133. PubMed PMID: 18464056. See more on PubMed
  • Liu RM, Eldridge S, Watanabe N, Deshane J, Kuo HC, Jiang C, Wang Y, Liu G,Schwiebert L, Miyata T, Thannickal VJ. Therapeutic potential of an orallyeffective small molecule inhibitor of plasminogen activator inhibitor for asthma.Am J Physiol Lung Cell Mol Physiol. 2016 Feb 15;310(4):L328-36. doi:10.1152/ajplung.00217.2015. Epub 2015 Dec 23. PubMed PMID: 26702150; PubMedCentral PMCID: PMC4754904. See more on PubMed
  • Matsumoto K, Inoue H, Fukuyama S, Kan-O K, Eguchi-Tsuda M, Matsumoto T,Moriwaki A, Nakano T, Nakanishi Y. Frequency of Foxp3+CD4CD25+ T cells isassociated with the phenotypes of allergic asthma. Respirology. 2009Mar;14(2):187-94. doi: 10.1111/j.1440-1843.2008.01472.x. Epub 2009 Jan 23. PubMedPMID: 19192224. See more on PubMed
  • Saito K, Torii M, Ma N, Tsuchiya T, Wang L, Hori T, Nagakubo D, Nitta N,Kanegasaki S, Hieshima K, Yoshie O, Gabazza EC, Katayama N, Shiku H, Kuribayashi K, Kato T. Differential regulatory function of resting and preactivatedallergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J Immunol. 2008 Nov 15;181(10):6889-97. PubMed PMID: 18981108. See more on PubMed
  • Yanase Y, Hiragun T, Uchida K, Ishii K, Oomizu S, Suzuki H, Mihara S, Iwamoto K, Matsuo H, Onishi N, Kameyoshi Y, Hide M. Peritoneal injection of fucoidansuppresses the increase of plasma IgE induced by OVA-sensitization. BiochemBiophys Res Commun. 2009 Sep 25;387(3):435-9. doi: 10.1016/j.bbrc.2009.07.031.Epub 2009 Jul 14. PubMed PMID: 19607810. See more on PubMed
Related Products Docs